Director, CEO · Ctt Pharmaceutical Holdings, Inc. · CTT PHARMACEUTICAL HOLDINGS, INC.
Side
BUY
Value
$450
Shares
9,000
Price
$0.05
Executed
Nov 4, 2026
Disclosed
Nov 6, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 4 executedNov 6, 2026 disclosed
CTTH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · CTTH
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Ctt Pharmaceutical Holdings, Inc. filed this Form 4 reporting a open-market purchase of CTTH on Nov 4, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO
Ctt Pharmaceutical Holdings, Inc.cik:0001035422
Issuer
Ctt Pharmaceutical Holdings, Inc.cik:0001035422
Revision history · 0
No field has changed since this record was first ingested.
